SCHEDULE 13G/A: BlackRock Amends Stake in Select Medical Holdings, Disclosing 15.5% Beneficial Ownership

BlackRock, Inc. has filed an amended Schedule 13G, revealing a 15.5% beneficial ownership stake in Select Medical Holdings Corp. as of December 31, 2024.

Summary

• BlackRock, Inc. reported beneficial ownership of 19,959,411 shares of Select Medical Holdings Corp. common stock.
• This represents 15.5% of the total outstanding common stock of Select Medical Holdings Corp.
• BlackRock holds sole voting power over 19,220,642 shares and sole dispositive power over 19,959,411 shares.
• No shared voting or dispositive power was reported by BlackRock.
• The filing is an Amendment No. 10 to the Schedule 13G, indicating a previous disclosure of ownership.
• One of BlackRock's entities, iShares Core S & P Small-Cap ETF, is noted to have an interest exceeding five percent of the total outstanding common stock of Select Medical Holdings Corp.

Sentiment

Score: 5

Explanation: The document is a factual, routine disclosure of beneficial ownership by an institutional investor. It contains no positive or negative performance indicators for the issuer, nor does it express sentiment regarding the investment beyond the required certification.

Positives

• BlackRock, a prominent institutional investor, maintains a significant 15.5% stake in Select Medical Holdings Corp., signaling continued investment interest.
• The majority of the shares (19,220,642 out of 19,959,411) are under BlackRock's sole voting power, indicating direct control over voting decisions for a substantial block of shares.

Future Outlook

The document does not provide any forward-looking statements or guidance regarding Select Medical Holdings Corp.'s future performance or BlackRock's future investment intentions beyond the current ownership disclosure.

Management Comments

• "The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11." (Certification by BlackRock, Inc.)

Industry Context

This Schedule 13G filing is a routine disclosure of an institutional investor's significant ownership stake and does not provide specific analysis of broader industry trends or competitive landscape within the healthcare services sector where Select Medical Holdings Corp. operates.

Stakeholder Impact

• Shareholders: BlackRock's significant stake (15.5%) means it holds substantial voting power, potentially influencing corporate decisions, although the filing states the shares are not held for control purposes.

Key Dates

Keywords

BlackRock, Select Medical Holdings Corp, SEC filing, Schedule 13G, beneficial ownership, institutional investor, common stock, equity stake, investment management, healthcare services